Process
10th Edition
• Author(s)Linda Lane Lilley;
Shelly Rainforth Collins; Julie
S. Snyder
Question 1
Item Type: MCQ
Clinical Scenario:
A newly licensed nurse is preparing to administer a medication
to a patient and notes that the drug has both a generic name
and several brand names. The patient asks why the medication
has different names.
,Question Stem:
When explaining drug nomenclature to the patient, which
statement about drug names is most accurate?
Answer Options:
A. "The brand name is assigned by the FDA to ensure
consistency across manufacturers."
B. "The chemical name describes the drug's molecular structure
and is used for clinical purposes."
C. "The generic name is the official nonproprietary name
assigned by the USAN Council."
D. "The trade name is always the same regardless of which
pharmaceutical company manufactures it."
Correct Answer: C
Comprehensive Rationale:
The generic name (nonproprietary name) is the official name
assigned by the United States Adopted Names (USAN) Council
and is used in official publications and formularies. Generic
names are standardized and must be used for all official drug
labeling. This is contrasted with:
• Chemical names describe the exact molecular structure
but are too complex for clinical use
• Brand/trade names are proprietary names assigned by
manufacturers and vary between companies
, • The FDA does not assign drug names; it reviews and
approves drugs for safety and efficacy
Distractor Analysis:
• Option A (Incorrect): Brand names are proprietary and
assigned by manufacturers, not the FDA. The FDA approves
drugs but does not create names. This misunderstanding
could lead to confusion about regulatory oversight.
• Option B (Incorrect): Chemical names describe molecular
structure but are too complex for clinical use. Using
chemical names in practice would be impractical and error-
prone.
• Option D (Incorrect): Trade names vary between
manufacturers; a drug may have multiple brand names.
This misconception could lead to duplicate therapy errors
if the same medication is prescribed under different brand
names.
Nursing Process Integration:
• Primary Component: Implementation (providing patient
education)
• Assessment: Understanding the patient's health literacy
and knowledge gaps
• Planning: Developing appropriate teaching strategies
, • Implementation: Providing clear, accurate medication
information
• Evaluation: Assessing patient understanding of medication
names
Clinical Judgment Measurement Model (NCJMM):
• Recognize Cues
• Generate Solutions
• Take Action
• Evaluate Outcomes
Difficulty: Easy
Bloom's Cognitive Level: Understand
NCLEX Client Needs: Pharmacological and Parenteral Therapies
Key Learning Objective: Differentiate among chemical, generic,
and brand names and understand their clinical implications for
safe medication administration.
Question 2
Item Type: SATA
Clinical Scenario:
A nursing instructor is teaching a pharmacology class about
drug development and the FDA approval process. A student